{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:16:15Z","timestamp":1790100975805,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T00:00:00Z","timestamp":1304294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00210-011-0636-8","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T10:45:35Z","timestamp":1304246735000},"page":"47-57","source":"Crossref","is-referenced-by-count":35,"title":["Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes"],"prefix":"10.1007","volume":"384","author":[{"given":"M.","family":"Kammerer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Rassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Freiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Feuerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,2]]},"reference":[{"key":"636_CR1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/sim.4780101206","volume":"10","author":"DG Altman","year":"1991","unstructured":"Altman DG (1991) Statistics in medical journals: developments in the 1980\u00a0s. Stat Med 10:1897\u20131913","journal-title":"Stat Med"},{"key":"636_CR2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2174\/1381612054021006","volume":"11","author":"JA Armijo","year":"2005","unstructured":"Armijo JA, Shushtarian M, Valdizan EM, Cuadrado A, de las Cuevas I, Ad\u00edn J (2005) Ion channels and epilepsy. Curr Pharm Des 11:1975\u20132003","journal-title":"Curr Pharm Des"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0896-6273(93)90145-H","volume":"11","author":"D Attwell","year":"1993","unstructured":"Attwell D, Barbour B, Szatkowski M (1993) Nonvesicular release of neurotransmitter. Neuron 11:401\u2013407","journal-title":"Neuron"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.ftd.0000158874.54100.1a","volume":"27","author":"D Berry","year":"2005","unstructured":"Berry D, Millington C (2005) Analysis of pregabalin at therapeutic concentrations in human plasma\/serum by reversed-phase HPLC. Ther Drug Monit 27:451\u2013456","journal-title":"Ther Drug Monit"},{"key":"636_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0922-4106(94)90089-2","volume":"269","author":"LA Borden","year":"1994","unstructured":"Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219\u2013224","journal-title":"Eur J Pharmacol"},{"key":"636_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00210-008-0370-z","volume":"379","author":"B Brawek","year":"2009","unstructured":"Brawek B, L\u00f6ffler M, Weyerbrock A, Feuerstein TJ (2009) Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes. Naunyn-Schmiedeberg's arch Pharmacol 379:361\u2013369","journal-title":"Naunyn-Schmiedeberg's arch Pharmacol"},{"key":"636_CR7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0896-6273(94)90260-7","volume":"13","author":"JN Cammack","year":"1994","unstructured":"Cammack JN, Rakhilin SV, Schwartz EA (1994) A GABA transporter operates asymmetrically and with variable stoichiometry. Neuron 13:949\u2013960","journal-title":"Neuron"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","volume":"13","author":"H Cheung","year":"1992","unstructured":"Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107\u2013112","journal-title":"Epilepsy Res"},{"key":"636_CR9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.1076510","volume":"298","author":"I Cohen","year":"2002","unstructured":"Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298:1418\u20131421","journal-title":"Science"},{"key":"636_CR10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0248-4900(03)00081-9","volume":"95","author":"I Cohen","year":"2003","unstructured":"Cohen I, Navarro V, Le Duigou C, Miles R (2003) Mesial temporal lobe epilepsy: a pathological replay of developmental mechanisms? Bio Cell 95:329\u2013333","journal-title":"Bio Cell"},{"key":"636_CR11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1528-1157.1987.tb03661.x","volume":"28","author":"JM Crowder","year":"1987","unstructured":"Crowder JM, Bradford HF (1987) Common anticonvulsants inhibit Ca2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia 28:378\u2013382","journal-title":"Epilepsia"},{"key":"636_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1059-1311(02)00295-9","volume":"12","author":"LD Errante","year":"2003","unstructured":"Errante LD, Petroff OA (2003) Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 12:300\u2013306","journal-title":"Seizure"},{"key":"636_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-1211(02)00034-7","volume":"49","author":"LD Errante","year":"2002","unstructured":"Errante LD, Williamson A, Spencer DD, Petroff OA (2002) Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 49:203\u2013210","journal-title":"Epilepsy Res"},{"key":"636_CR14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.bjp.0703380","volume":"130","author":"K Fink","year":"2000","unstructured":"Fink K, Meder W, Dooley DJ, G\u00f6thert M (2000) Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 130:900\u2013906","journal-title":"Br J Pharmacol"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","volume":"42","author":"K Fink","year":"2002","unstructured":"Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, G\u00f6thert M (2002) Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42:229\u2013236","journal-title":"Neuropharmacology"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","volume":"271","author":"NS Gee","year":"1996","unstructured":"Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271:5768\u20135776","journal-title":"J Biol Chem"},{"key":"636_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","volume":"25","author":"SI Johannessen","year":"2003","unstructured":"Johannessen SI, Battine D, Berry DJ, Bialer M, Kr\u00e4mer G, Tomson T, Patsalos PN (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25:347\u2013363","journal-title":"Ther Drug Monit"},{"issue":"Suppl 1","key":"636_CR18","first-page":"47","volume":"381","author":"M Kammerer","year":"2010","unstructured":"Kammerer M, Rassner M, Freiman TM, Feuerstein TJ (2010) Effects of antiepileptic drugs on GABA release in rat and human neocortical synaptosomes. Naunyn-Schmiedeberg's arch Pharmacol 381(Suppl 1):47","journal-title":"Naunyn-Schmiedeberg's arch Pharmacol"},{"key":"636_CR19","doi-asserted-by":"crossref","unstructured":"Kammerer M, Brawek B, Freiman TM, Jackisch R, Feuerstein TJ (2011) Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol (in press)","DOI":"10.1007\/s00210-011-0620-3"},{"key":"636_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(90)90416-7","volume":"166","author":"MK Kelly","year":"1990","unstructured":"Kelly MK, Gross RA, Macdonald RL (1990) Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett 166:233\u2013238","journal-title":"Neurosci Lett"},{"key":"636_CR21","first-page":"1","volume":"13","author":"CJ Landmark","year":"2007","unstructured":"Landmark CJ (2007) Targets for antiepileptic drugs in the synapse. Med Sci Monit 13:1\u20137","journal-title":"Med Sci Monit"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0028-3908(01)00140-X","volume":"41","author":"C Lanneau","year":"2001","unstructured":"Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, Charles KJ, Wood M, Davies Ch, Pangalos MN (2001) Gabapentin is not a GABAB receptor agonist. Neuropharmacology 41:965\u2013975","journal-title":"Neuropharmacology"},{"key":"636_CR23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","volume":"27","author":"MJ Leach","year":"1986","unstructured":"Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490\u2013497","journal-title":"Epilepsia"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0920-1211(97)01034-6","volume":"27","author":"JP Leach","year":"1997","unstructured":"Leach JP, Sills GJ, Butler E, Forrest G, Thompson GG, Brodie MJ (1997) Neurochemical actions of gabapentin in mouse brain. Epilepsy Res 27:175\u2013180","journal-title":"Epilepsy Res"},{"key":"636_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00964616","volume":"5","author":"G Levi","year":"1980","unstructured":"Levi G, Gallo V, Raiteri M (1980) A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings. Neurochem Res 5:281\u2013295","journal-title":"Neurochem Res"},{"key":"636_CR26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0028-3908(81)90062-9","volume":"20","author":"W L\u00f6scher","year":"1981","unstructured":"L\u00f6scher W, B\u00f6hme G, Sch\u00e4fer H, Kochen W (1981) Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings. Neuropharmacology 20:1187\u20131192","journal-title":"Neuropharmacology"},{"key":"636_CR27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1085\/jgp.114.3.429","volume":"114","author":"CC Lu","year":"1999","unstructured":"Lu CC, Hilgemann DW (1999) GAT1 (GABA:Na+:Cl\u2212) cotransport function. Steady state studies in giant Xenopus oocyte membrane patches. J Gen Physiol 114:429\u2013444","journal-title":"J Gen Physiol"},{"key":"636_CR28","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammens P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1157.1982.tb06093.x","volume":"23","author":"RL Macdonald","year":"1982","unstructured":"Macdonald RL, McLean MJ (1982) Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 23:7\u201318","journal-title":"Epilepsia"},{"key":"636_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/WCO.0b013e3282f52f5f","volume":"21","author":"EO Mann","year":"2008","unstructured":"Mann EO, Mody I (2008) The multifaceted role of inhibition in epilepsy: seizure-genesis through excessive GABAergic inhibition in autosomal dominant nocturnal frontal lobe epilepsy. Curr Opin Neurol 21:155\u2013160","journal-title":"Curr Opin Neurol"},{"key":"636_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-009-0410-3","volume":"380","author":"M Mantovani","year":"2009","unstructured":"Mantovani M, Moser A, Haas CA, Zentner J, Feuerstein TJ (2009) GABAA autoreceptors enhance GABA release from human neocortex: towards a mechanism for high-frequency stimulation (HFS) in brain? Naunyn-Schmiedberg\u00b4s arch Pharmacol 380:45\u201358","journal-title":"Naunyn-Schmiedberg\u00b4s arch Pharmacol"},{"key":"636_CR32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","volume":"237","author":"MJ McLean","year":"1986","unstructured":"McLean MJ, Macdonald RL (1986a) Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 237:1001\u20131011","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(25)24848-0","volume":"238","author":"MJ McLean","year":"1986","unstructured":"McLean MJ, Macdonald RL (1986b) Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potential of mouse central neurons in cell culture. J Pharmacol Exp Ther 238:727\u2013738","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0005-2728(05)80210-5","volume":"1059","author":"HT McMahon","year":"1991","unstructured":"McMahon HT, Nicholls DG (1991) The bioenergetics of neurotransmitter release. Biochim Biophys Acta 1059:243\u2013264","journal-title":"Biochim Biophys Acta"},{"key":"636_CR35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/mol.106.023309","volume":"70","author":"KD Micheva","year":"2006","unstructured":"Micheva KD, Taylor CP, Smith SJ (2006) Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol 70:467\u2013476","journal-title":"Mol Pharmacol"},{"key":"636_CR36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90687-7","volume":"457","author":"D Minc-Golomb","year":"1988","unstructured":"Minc-Golomb D, Eimerl S, Levy Y, Schramm M (1988) Release of D-[3H]aspartate and [14C]GABA in rat hippocampus slices: effects of fatty acid-free bovine serum albumin and Ca2+ withdrawal. Brain Res 457:205\u2013211","journal-title":"Brain Res"},{"key":"636_CR37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","volume":"46","author":"RG Morris","year":"1998","unstructured":"Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC (1998) Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 46:547\u2013551","journal-title":"Br J Clin Pharmacol"},{"key":"636_CR38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1432-1033.1993.tb17700.x","volume":"212","author":"DG Nicholls","year":"1993","unstructured":"Nicholls DG (1993) The glutamatergic nerve terminal. Eur J Biochem 212:613\u2013631","journal-title":"Eur J Biochem"},{"key":"636_CR39","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/0006-2952(82)90111-3","volume":"31","author":"NI Phillips","year":"1982","unstructured":"Phillips NI, Fowler LJ (1982) The effects of sodium valproate on \u03b3-aminobutyrate metabolism and behaviour in na\u00efve and ethanolamine-O-sulphate pretreated rats and mice. Biochem Pharmacol 31:2257\u20132261","journal-title":"Biochem Pharmacol"},{"key":"636_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/16697","volume":"397","author":"C Rivera","year":"1999","unstructured":"Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U, Saarma M, Kaila K (1999) The K+\/Cl\u2212 co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397:251\u2013255","journal-title":"Nature"},{"key":"636_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, L\u00f6scher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553\u2013564","journal-title":"Nat Rev Neurosci"},{"key":"636_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-2952(92)90013-9","volume":"44","author":"MS Santos","year":"1992","unstructured":"Santos MS, Rodriguez R, Carvalho AP (1992) Effect of depolarizing agents on the Ca2+-independent and Ca2+-dependent release of [3H]GABA from sheep brain synaptosomes. Biochem Pharmacol 44:301\u2013308","journal-title":"Biochem Pharmacol"},{"key":"636_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1528-1157.1998.tb01387.x","volume":"39","author":"TB Schumacher","year":"1998","unstructured":"Schumacher TB, Beck H, Steinh\u00e4user C, Schramm J, Elger CE (1998) Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia 39:355\u2013363","journal-title":"Epilepsia"},{"key":"636_CR44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neuropharm.2007.08.016","volume":"53","author":"M Sitges","year":"2007","unstructured":"Sitges M, Guarneros A, Nekrassov V (2007) Effect of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]-glutamate: comparison with the Na + channel-mediated release. Neuropharmacology 53:854\u2013862","journal-title":"Neuropharmacology"},{"key":"636_CR45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1469-7793.1999.0693n.x","volume":"519","author":"KJ Staley","year":"1999","unstructured":"Staley KJ, Proctor WR (1999) Modulation of mammalian dendritic GABAA receptor function by the kinetics of Cl\u2212 and HCO 3 \u2212 transport. J Physiol 519:693\u2013712","journal-title":"J Physiol"},{"key":"636_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)21001-1","volume":"246","author":"DA Twombly","year":"1988","unstructured":"Twombly DA, Yoshii M, Narahashi T (1988) Mechanisms of calcium channel block by phenytoin. J Pharmacol Exp Ther 246:189\u2013195","journal-title":"J Pharmacol Exp Ther"},{"key":"636_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(96)00384-7","volume":"7","author":"J Wegerer von","year":"1997","unstructured":"von Wegerer J, He\u00dflinger B, Berger M, Walden J (1997) A calcium antagonistic effect of the new antiepileptic drug lamotrigine. Eur Neuropharmacol 7:77\u201381","journal-title":"Eur Neuropharmacol"},{"key":"636_CR48","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-09-0494","volume":"15","author":"MT Voso","year":"2009","unstructured":"Voso MT et al (2009) Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15:5002\u20135007","journal-title":"Clin Cancer Res"},{"key":"636_CR49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0924-977X(92)90009-W","volume":"2","author":"J Walden","year":"1992","unstructured":"Walden J, Grunze H, Bingmann D, Liu Z, D\u00fcsing R (1992) Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies. Eur Neuropsychopharmacol 2:455\u2013462","journal-title":"Eur Neuropsychopharmacol"},{"key":"636_CR50","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.45.10.1907","volume":"45","author":"PC Waldmeier","year":"1995","unstructured":"Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907\u20131913","journal-title":"Neurology"},{"key":"636_CR51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.neuron.2007.10.021","volume":"56","author":"Y Wu","year":"2007","unstructured":"Wu Y, Wang W, Diez-Sampedro A, Richerson GB (2007) Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56:851\u2013865","journal-title":"Neuron"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-011-0636-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0636-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:47:13Z","timestamp":1741150033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-011-0636-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s00210-011-0636-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,2]]}}}